Vous avez cherché: mouse (Anglais - Maltais)

mouse
ġurdien

knockout mouse
ġurdien knockout

shark bay mouse
Ġurdien ta’ shark bay

hypersensitivity to mouse proteins.
ipersensittività għall-proteini tal-ġrieden.

dwarf lemurs and mouse lemurs
lemuri nani u lemuri ġrieden

human anti-mouse antibody (hama)
human anti- mouse antibody (hama)

ceprotin including mouse protein or heparin.
sustanza oħra ta 'ceprotin inkluż il- proteina tal- ġrieden jew l- eparina.

the product contains traces of mouse proteins.
il-prodott fih traċċi ta’ proteini tal-ġrieden.

if you are allergic to mouse or hamster protein.
jekk inti allerġiku/a għall-proteina li ġejja mill-ġrieden jew mill-ħamsters.

in mouse, chronic ulcerative skin lesions were increased.
fil-ġrieden, leżjonijiet ulċerattivi kroniċi fil-ġilda, żdiedu.

the relevance of this mouse data to humans is unknown.
ir-relevanza ta' dan it-tagħrif fil- ġrieden għall-bniedem mhix mgħarufa.

the product contains traces of mouse and hamster proteins.
il-prodott fih traċċi ta’ proteini tal-ġurdien u tal-ħamster.

europe’s cultural heritage at the click of a mouse
il-maws muftieħ tal-wirt kulturali tal-ewropa

naltrexone was also negative in an in vivo mouse micronucleus assay.
naltrexone ta’ riżultat negattiv ukoll fl- assaġġ ta’ mikronukleju fil-ġurdien in vivo.

protein c from human plasma purified by mouse monoclonal antibodies.
proteina Ċ mill-plażma tal-bniedem ppurifikata b’antikorpi monoklonali tal-ġurdien.

personal computers (cpu, mouse, screen and keyboard included)
komputers personali (bis-cpu, screen u l-keyboard inklużi)

positive screening test for human anti-mouse antibody (hama).
eżami pożittiv għal antikorp tal-bniedem kontra l-ġurdien (hama).

vandetanib has shown no carcinogenic potential in a transgenic mouse carcinogenicity study.
vandetarib ma wera ebda potenzjal karċinoġeniku fi studju transġeniku tal-kanċeroġeniċità fil- ġrieden.

the active substance, infliximab, is a human-mouse monoclonal antibody.
is- sustanza attiva, infliximab, hija antikorp monoklonali uman- ġurdien.

in syngeneic mouse models, blocking pd-1 activity resulted in decreased tumour growth.
f’mudelli tal-ġrieden sinġeneiċi, l-imblukkar tal-attività ta’ pd-1 irriżulta fi tkabbir imnaqqas tat-tumur.